AstraZeneca gets $486 million to test and manufacture COVID-19 antibody therapy
Update: 2025-10-09
Description
AstraZeneca has received nearly 500 million dollars to test an experimental COVID-19 antibody cocktail. The cocktail is a combination of two monoclonal antibodies that target different surfaces on SARS-CoV-2, the virus that causes COVID-19The treatment, could prevent infections for up to a year afte....
This item belongs to: audio/rivet360-audio-collection.
This item has files of the following types: Archive BitTorrent, Columbia Peaks, Item Tile, Metadata, PNG, Spectrogram, VBR MP3
Comments
In Channel